We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Finger Scanner for Malaria to Be Developed

By LabMedica International staff writers
Posted on 13 May 2010
An optomagnetic finger scanner is being developed for the diagnosis of malaria.

The noninvasive finger scanner will detect the presence of malarial hemozoin crystals in infected individuals. More...
Hemozoin is the iron-containing pigment, which accumulates as cytoplasmic granules in malaria parasites and is a breakdown product of hemoglobin.

Light-emitting diodes, magnets, and electronic components available to do-it-yourself hobbyists will be used for constructing the instrument. In contrast to the test under development, current diagnosis of malaria is performed using invasive blood tests requiring sizable equipment.

On May 11, 2010, the DNA Medicine Institute (Cambridge, MA, USA) announced that it received a US $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation (Seattle, WA, USA) to develop the optomagnetic finger scanner. The project will be conducted by the DNA Medicine Institute's Eugene Y. Chan, M.D.

"I am pleased to have the opportunity to pursue an idea that pushes the envelope of malaria diagnosis. Malaria is a deadly disease that afflicts up to 500 million people each year. Millions die from it, including many young children in developing countries. My group is developing a tiny device that scans a finger, without any blood [sample], to allow anyone, anytime, and anywhere to check for malaria infection," said Dr. Chan.

Related Links:
DNA Medicine Institute
Bill & Melinda Gates Foundation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.